<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00299039</url>
  </required_header>
  <id_info>
    <org_study_id>CDHA008</org_study_id>
    <nct_id>NCT00299039</nct_id>
  </id_info>
  <brief_title>T3AI-Pain After Breast Surgery</brief_title>
  <acronym>T3AI</acronym>
  <official_title>A Randomized Controlled Trial Comparing Combination Therapy of Acetaminophen Plus Ibuprofen Versus Tylenol #3® for the Treatment of Pain After Breast Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nova Scotia Health Authority</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nova Scotia Health Authority</source>
  <brief_summary>
    <textblock>
      Current standard of care for post-operative analgesia after breast surgery in CDHA is Tylenol
      #3® (300 mg acetaminophen, 30 mg codeine, 15 mg caffeine per tablet). We are proposing to
      test the analgesic efficacy of acetaminophen plus ibuprofen against Tylenol #3® in patients
      undergoing outpatient breast surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Block randomization will be used to randomize patients to one of two combinations. Group A
      will receive capsules containing 650 mg Acetaminophen plus 400 mg Ibuprofen. Group B will
      receive capsules containing 600 mg Acetaminophen, 15 mg caffeine and 60 mg codeine. Capsules
      are placed in identical dossettes containing a seven day supply. Patients are instructed to
      start taking their medications post-op and continue until they are pain free. All
      participants are given a series of blank Visual Analogue scales and Likert scales and
      instructed to record their level of pain intensity and pain relief four times per day for the
      entire week. Peri-operative pain management will be standardized. Patients will not receive
      pre-operative analgesics. Intra-operative analgesia will be intravenous opioids as selected
      by anaesthesiology. No local/regional anaesthesia will be used. Intravenous ketorolac will
      not be allowed for trial participants. All patients will receive intravenous opioid and
      anti-emetic if required in PACU. Any patients with peri-operative complications or other
      problems requiring admission or alternative analgesics will be excluded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS Scores.</measure>
    <time_frame>mean and daily</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>maximum VAS scores.</measure>
    <time_frame>daily</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Likert scores.</measure>
    <time_frame>mean daily and final</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient satisfaction with analgesic regimen.</measure>
    <time_frame>day 7</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment failures-inadequate pain relief or inability to tolerate side effects.</measure>
    <time_frame>daily</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to stopping medication.</measure>
    <time_frame>day 7</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Pain relief (TOTPAR).</measure>
    <time_frame>daily</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sum of pain intensity differences (SPID).</measure>
    <time_frame>day7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of medication used.</measure>
    <time_frame>day 7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of side effects.</measure>
    <time_frame>day 7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance with regimen.</measure>
    <time_frame>day 7</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Pain</condition>
  <condition>Breast Diseases</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>acetaminophen plus codeine</intervention_name>
    <description>capsules four times daily until pain free or for a maximum of seven days</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>acetaminophen plus ibuprofen</intervention_name>
    <description>capsules four times daily until pain free or for a maximum of seven days</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ages 18 to 70 inclusive

          -  outpatient breast surgery: lumpectomy; mastectomy, simple or modified; with or without
             sentinel lymph node biopsy, axillary node dissection.

        Exclusion Criteria:

          -  allergies to acetaminophen, NSAIDs, ASA or codeine.

          -  asthma.

          -  recent reported history of upper GI bleeding.

          -  daily analgesic use (OTC or opioid) pre-operatively.

          -  any opioid use in the week prior to surgery.

          -  reported history of PUD if not on PPI regularly.

          -  anticoagulant use (low dose ASA excepted).

          -  renal disease or impairment.

          -  reported history of liver disease.

          -  pregnancy.

          -  major operative complications.

          -  patients requiring admission.

          -  communication barrier.

          -  cognitive or memory impairment.

          -  reported history of drug and/or alcohol abuse.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alex D Mitchell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CDHA, Dalhousie University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>QEII Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 2Y9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2006</study_first_submitted>
  <study_first_submitted_qc>March 3, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2006</study_first_posted>
  <last_update_submitted>January 30, 2009</last_update_submitted>
  <last_update_submitted_qc>January 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Alex Mitchell</name_title>
    <organization>Dalhousie University</organization>
  </responsible_party>
  <keyword>Randomized controlled trial</keyword>
  <keyword>Clinical trial</keyword>
  <keyword>Breast tumor surgery</keyword>
  <keyword>Outpatient surgery</keyword>
  <keyword>Analgesia</keyword>
  <keyword>Outpatient analgesia</keyword>
  <keyword>Post surgical analgesia</keyword>
  <keyword>≥ 18 and ≤ 70 years of age</keyword>
  <keyword>Elective outpatient breast surgery for:</keyword>
  <keyword>lumpectomy/quadrantectomy +/- Sentinel Lymph Node Biopsy</keyword>
  <keyword>lumpectomy/quadrantectomy with Axillary Node Dissection</keyword>
  <keyword>simple mastectomy +/- Sentinel Lymph Node Biopsy</keyword>
  <keyword>Modified Radical mastectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Codeine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

